IOVANCE BIOTHERAPEUTICS, INC.
Tremor tracks 9 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
Trials
- IOVAIovance Biotherapeutics, Inc.0Calm
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma
Signing up patientsPhase 280 patientsMain results: Sep 1, 2033 - IOVAIovance Biotherapeutics, Inc.0Calm
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma
Running, no new patientsPhase 224 patientsMain results: Dec 2027 - IOVAIovance Biotherapeutics, Inc.0Calm
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Signing up patientsPhase 3670 patientsMain results: Mar 1, 2028 - IOVAIovance Biotherapeutics, Inc.0Calm
A Study of IOV-5001 in Adults With Advanced Solid Tumors
Not started yetPhase 1/2106 patientsMain results: Mar 2034 - IOVAIovance Biotherapeutics, Inc.0Calm
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Signing up patientsPhase 2170 patientsMain results: Dec 2030 - IOVAIovance Biotherapeutics, Inc.0Calm
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
Signing up patientsPhase 1/242 patientsMain results: Jun 2032 - IOVAIovance Biotherapeutics, Inc.0Calm
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Signing up patientsPhase 1/253 patientsMain results: Sep 2027 - IOVAIovance Biotherapeutics, Inc.0Calm
Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma
FinishedPhase 2220 patientsMain results: Oct 24, 2024 - IOVAIovance Biotherapeutics, Inc.0Calm
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
Signing up patientsPhase 260 patientsMain results: May 2028
Key executives leaving
From the last 12 months of the company's SEC reports.
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
0 sales (0 not pre-planned) · 0 purchases
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.